European and US guidelines for arterial hypertension: similarities and differences

被引:25
作者
Angeli, Fabio [1 ]
Reboldi, Gianpaolo [2 ]
Trapasso, Monica [2 ]
Gentile, Giorgio [2 ]
Pinzagli, Maria Gabriella [3 ,4 ]
Aita, Adolfo [3 ,4 ]
Verdecchia, Paolo [3 ,4 ]
机构
[1] Hosp S Maria della Misericordia, Div Cardiol & Cardiovasc Pathophysiol, Perugia, Italy
[2] Univ Perugia, Dept Med, Perugia, Italy
[3] Hosp S Maria della Misericordia, Fdn Umbra Cuore & Ipertens ONLUS, Perugia, Italy
[4] Hosp S Maria della Misericordia, Div Cardiol, Perugia, Italy
关键词
Blood pressure; Hypertension; Guidelines; Therapy; Prognosis; BLOOD-PRESSURE CONTROL; CORONARY-HEART-DISEASE; RISK; PREVENTION; TRIAL; RECOMMENDATIONS; ASSOCIATION; PREVALENCE; AMLODIPINE; REDUCTION;
D O I
10.1016/j.ejim.2019.01.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is one of the most common chronic diseases in adults and a leading cause of disability and mortality worldwide. Recently, new Guidelines for the diagnosis and management of hypertension have been released in Europe and in the United States, with changes regarding how to diagnose and treat the condition, and the extent to which intensive blood pressure control should be pursued. Important differences between the Guidelines exist in the classification of blood pressure levels and definition of treatment goals. Diagnosis of hypertension starts at 140/90 mmHg for the European Guidelines, and 130/80 mmHg for the US Guidelines. Besides, the European guidelines introduced the concept of "safety boundaries", consisting of BP thresholds not to be exceeded towards lower levels (120 mmHg for age < 65 years, 130 mmHg for older people) because of the fear of important adverse events associated with overtreatment. Such discrepancies can indeed have an impact on treatment attitudes and outcome incidence. Hence, we appraised facts in favor and against each of these controversial issues. In conclusion we believe that, instead of fixing rigid BP targets and boundaries, modern hypertension management should be aimed to achieve in each patient an optimal balance between intensive BP reduction and treatment safety.
引用
收藏
页码:3 / 8
页数:6
相关论文
共 35 条
[1]  
Angeli F, 2012, EXPERT REV CARDIOVAS, V10, P1467, DOI [10.1586/ERC.12.151, 10.1586/erc.12.151]
[2]   White-coat UnControlled Hypertension, Masked UnControlled Hypertension, and True UnControlled Hypertension, phonetic and mnemonic terms for treated hypertension phenotypes [J].
Banegas, Jose R. ;
Ruilope, Luis M. ;
Williams, Bryan .
JOURNAL OF HYPERTENSION, 2018, 36 (02) :446-447
[3]   Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials [J].
Bangalore, Sripal ;
Toklu, Bora ;
Gianos, Eugenia ;
Schwartzbard, Arthur ;
Weintraub, Howard ;
Ogedegbe, Gbenga ;
Messerli, Franz H. .
AMERICAN JOURNAL OF MEDICINE, 2017, 130 (06) :707-U382
[4]   Outcomes of Intensive Blood Pressure Lowering in Older Hypertensive Patients [J].
Bavishi, Chirag ;
Bangalore, Sripal ;
Messerli, Franz H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (05) :486-493
[5]   Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality A Systematic Review and Network Meta-analysis [J].
Bundy, Joshua D. ;
Li, Changwei ;
Stuchlik, Patrick ;
Bu, Xiaoqing ;
Kelly, Tanika N. ;
Mills, Katherine T. ;
He, Hua ;
Chen, Jing ;
Whelton, Paul K. ;
He, Jiang .
JAMA CARDIOLOGY, 2017, 2 (07) :775-781
[6]   Expert recommendations on the challenges of hypertension in Asia [J].
Chung, N. ;
Baek, S. ;
Chen, M. -F. ;
Liau, C. -S. ;
Park, C. G. ;
Park, J. ;
Saruta, T. ;
Shimamoto, K. ;
Wu, Z. ;
Zhu, J. ;
Fujita, T. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (09) :1306-1312
[7]   2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk [J].
Colantonio, Lisandro D. ;
Booth, John N., III ;
Bress, Adam P. ;
Whelton, Paul K. ;
Shimbo, Daichi ;
Levitan, Emily B. ;
Howard, George ;
Safford, Monika M. ;
Muntner, Paul .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (11) :1187-1197
[8]   Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial [J].
Dahlöf, B ;
Sever, PS ;
Poulter, NR ;
Wedel, H ;
Beevers, DG ;
Caulfield, M ;
Collins, R ;
Kjeldsen, SE ;
Kristinsson, A ;
McInnes, GT ;
Mehlsen, J ;
Nieminen, M ;
O'Brien, E ;
Östergren, J .
LANCET, 2005, 366 (9489) :895-906
[9]   Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis [J].
Ettehad, Dena ;
Emdin, Connor A. ;
Kiran, Amit ;
Anderson, Simon G. ;
Callender, Thomas ;
Emberson, Jonathan ;
Chalmers, John ;
Rodgers, Anthony ;
Rahimi, Kazem .
LANCET, 2016, 387 (10022) :957-967
[10]  
Franklin SS, 2001, CIRCULATION, V103, P1245